Cours Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Actions
IL0006290147
Produits pharmaceutiques
CA 2024 * | 15,95 Md 59,23 Md 14,49 Md | CA 2025 * | 16,52 Md 61,33 Md 15,01 Md | Capitalisation | 19,12 Md 70,98 Md 17,37 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 820 M 3,04 Md 745 M | Résultat net 2025 * | 1,39 Md 5,15 Md 1,26 Md | VE / CA 2024 * | 2,13 x |
Dette nette 2024 * | 14,93 Md 55,41 Md 13,56 Md | Dette nette 2025 * | 12,41 Md 46,07 Md 11,27 Md | VE / CA 2025 * | 1,91 x |
PER 2024 * |
18
x | PER 2025 * |
12,5
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 89,71% |
Dernier transcript sur Teva Pharmaceutical Industries Limited
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,98% | 684 Md | |
+30,34% | 568 Md | |
-3,52% | 361 Md | |
+18,59% | 329 Md | |
+4,07% | 284 Md | |
+16,21% | 240 Md | |
+9,66% | 208 Md | |
-6,83% | 200 Md | |
+7,09% | 166 Md |